Article
Medicine, Research & Experimental
Shashi Bala, Yuan Zhuang, Prashanth Thevkar Nagesh, Donna Catalano, Adam Zivny, Yanbo Wang, Jun Xie, Guangping Gao, Gyongyi Szabo
Summary: This study investigated the therapeutic effect of miR-155 inhibition in liver fibrosis and found that miR-155 deficiency can significantly reduce liver fibrosis. The study also revealed that miR-155 regulates activation of hepatic stellate cells partly via STAT3 signaling.
MOLECULAR THERAPY-NUCLEIC ACIDS
(2023)
Article
Medicine, General & Internal
Jian Zang, Bo Yang, Shuai Feng, Xuejun Jiang
Summary: The study revealed down-regulation of miR-125b and up-regulation of STAT3, cyclin D1, survivin, and VEGF in cholesteatoma tissues. STAT3 was identified as a direct target of miR-125b. Inhibition of miR-125b enhanced STAT3 and downstream gene expression, promoting cell proliferation and inhibiting apoptosis.
ARCHIVES OF MEDICAL SCIENCE
(2022)
Article
Gastroenterology & Hepatology
Wei Yu, Inamul Haque, Aparna Venkatraman, Heather L. Menden, Sherry M. Mabry, Badal C. Roy, Sheng Xia, Jeremy W. Prokop, Shahid Umar, Aron M. Geurts, Venkatesh Sampath
Summary: This study identified a novel pathway (SIGIRR-STAT3-miRNA-IRAK1 repression) by which SIGIRR regulates postnatal intestinal adaptation, disrupted by a SIGIRR mutation identified in human NEC. These data provide new insights into how human genetic mutations in SIGIRR identified in NEC result in loss of postnatal intestinal immune tolerance.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Zhi-Qun Zhang, Hui Hong, Jing Li, Xiao-Xia Li, Xian-Mei Huang
Summary: The study shows that miR-214 may promote alveolarization in preterm neonates with BPD by inhibiting the PlGF-dependent STAT3 pathway.
MOLECULAR MEDICINE
(2021)
Article
Cell Biology
Ruowen Gong, Ruyi Han, Xiaonan Zhuang, Wenyi Tang, Gezhi Xu, Lei Zhang, Jihong Wu, Jun Ma
Summary: miR-375 regulates proliferation and angiogenesis of retinal microvascular endothelial cells through the JAK2/STAT3 pathway, providing important insights into the mechanisms of retinal angiogenesis and potential therapeutic targets for retinal microangiopathy.
Review
Cardiac & Cardiovascular Systems
Lan Wu, Zhizheng Li, Yanfei Li
Summary: STAT3, as a transcription factor and signaling molecule, plays an important role in cardiac disease and protection. It regulates the expression of genes involved in oxidation, apoptosis, inflammation, and fibrosis. Additionally, it is also targeted and regulated by miRNAs, which further modulate the mRNA expression profiles in cardiomyocytes and impact cardiac disease and protection.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Oncology
Mirco Di Marco, Serena Veschi, Paola Lanuti, Alice Ramassone, Stefania Pacillo, Sara Pagotto, Felice Pepe, Jonahunnatha Nesson George-William, Claudia Curcio, Marco Marchisio, Sebastiano Miscia, Idanna Innocenti, Francesco Autore, Barbara Vannata, Patrizia Di Gregorio, Mario Di Gioacchino, Silvia Valentinuzzi, Manuela Iezzi, Renato Mariani-Costantini, Luigi Maria Larocca, Luca Laurenti, Angelo Veronese, Rosa Visone
Summary: The research shows that miR-181b can increase its expression in CLL cells by interacting with CD40L(+) T cells, enhancing the differentiation of CD8(+) T cells into cytotoxic T lymphocytes (CTL) and strengthening the immune response against tumor cells.
Article
Cell Biology
Jian Bai, Xue Zhang, Dongdong Shi, Zhenxian Xiang, Shuyi Wang, Chaogang Yang, Qing Liu, Sihao Huang, Yan Fang, Weisong Zhang, Jialin Song, Bin Xiong
Summary: The study revealed that miR-128-3p regulates EMT between CRC cells through exosomal delivery by directly suppressing FOXO4 to activate TGF-beta/SMAD and JAK/STAT3 signaling pathways. High expression of miR-128-3p was significantly associated with pathological features in CRC patients, suggesting that exosomal miR-128-3p could serve as a novel therapeutic approach for CRC.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Article
Biology
Nader Davari, Fatemeh Ahmadpour, Ali Asghar Kiani, Mozhgan Azadpour, Zari Tahannejad Asadi
Summary: In patients with CLL, the expression of miR-125a and miR-223 decreases, while the expression of BCL-2 and STAT3 increases. These miRs may have regulatory effects by controlling white blood cell production, as evidenced by the inverse correlation with WBC count and Hb concentration.
BMC RESEARCH NOTES
(2021)
Article
Medicine, General & Internal
Hui Li, Hui-Min Zhang, Li-Juan Fan, Han-Han Li, Zi-Tan Peng, Jia-Peng Li, Xiao-Yu Zhang, Yuan Xiang, Chao-Jiang Gu, Xing-Hua Liao, Li Wang, Tong-Cun Zhang
Summary: Endothelial cell proliferation disorder caused by vascular injury may be one of the causes of atherosclerosis, and miR-15a-5p could be a therapeutic target for coronary artery atherosclerosis.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
(2021)
Article
Pharmacology & Pharmacy
Jinyu Wang, Xueyun Zhang, Jiajia Han, Pu Zhou, Xueping Yu, Zhongliang Shen, Richeng Mao, Mengji Lu, Yuxian Huang, Jiming Zhang
Summary: This study reveals that serum miR-124 can serve as a compensatory predictive factor for organ failure and the 28-day prognosis in patients with HBV-ACLF. Moreover, miR-124 overexpression can decrease IL-6 secretion and relieve liver necrosis by targeting the 3′-untranslated region of STAT3 and inhibiting IL-6/STAT3 signaling. These findings suggest that miR-124 may have potential as a biomarker and therapeutic target for severe liver injury.
ANTIVIRAL RESEARCH
(2023)
Article
Multidisciplinary Sciences
Xiangke Cao, Qinghua Ma, Bin Wang, Qingqiang Qian, Yinan Xi
Summary: Circ-E2F3 is upregulated in cervical cancer tissues and cell lines, correlating with clinicopathological features and poor prognosis of patients. It promotes proliferation, invasion, migration of cancer cells, and tumor growth in vivo, by inhibiting miR-296-5p to facilitate nuclear translocation of STAT3 and affect cyclin D1 expression.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
(2022)
Article
Oncology
Yingying Huang, Xiaoxiao Du, Xiangliu Chen, Chuanzhi Chen, Haiyong Wang, Yan Yang, Lisong Teng
Summary: The study found that highly expressed miR-301a-5p is associated with the aggressiveness of gastric cancer, promoting malignant phenotype by targeting SCIN. Further investigation revealed that alterations in miR-301a-5p levels could impact the epithelial-mesenchymal transition (EMT) process in gastric cancer cells.
Article
Biochemistry & Molecular Biology
Jung Hun Lee, Eun Hee Ahn, Min Jung Kwon, Chang Su Ryu, Yong Hyun Ha, Eun Ju Ko, Jeong Yong Lee, Ji Young Hwang, Ji Hyang Kim, Young Ran Kim, Nam Keun Kim
Summary: This study investigated the association between miRNA genetic variants and recurrent implantation failure (RIF) risk in Korean population, and found that miR-34a rs6577555 C>A was significantly associated with RIF prevalence, suggesting its potential role in increased susceptibility to RIF. Further research is needed to understand the precise mechanisms underlying this association.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Review
Medicine, Research & Experimental
Sepideh Mirzaei, Mohammad Hossein Gholami, Mahmood Khaksary Mahabady, Noushin Nabavi, Amirhossein Zabolian, Seyed Mohammad Banihashemi, Amirabbas Haddadi, Maliheh Entezari, Kiavash Hushmandi, Pooyan Makvandi, Saeed Samarghandian, Ali Zarrabi, Milad Ashrafizadeh, Haroon Khan
Summary: Effective cancer therapy requires the identification of signaling networks, with STAT3 playing a significant role in promoting proliferation, invasion, chemoresistance, and metastasis in bladder cancer cells. Inhibiting STAT3 may enhance chemotherapy efficacy by overcoming chemoresistance in BC. Multiple molecular pathways and non-coding RNAs act as upstream regulators of STAT3 in BC cells.
BIOMEDICINE & PHARMACOTHERAPY
(2021)
Article
Cell Biology
Fabiana Tortora, George A. Calin, Amelia Cimmino
Summary: Non-coding RNAs, especially long ncRNAs, play a crucial role in cancer progression by influencing physiological processes, particularly in genitourinary neoplasms. Their dysregulation can be significant for cancer onset and progression.
MOLECULAR AND CELLULAR ENDOCRINOLOGY
(2021)
Editorial Material
Biochemistry & Molecular Biology
Swati Mohapatra, George Calin
CELL DEATH AND DIFFERENTIATION
(2021)
Article
Biotechnology & Applied Microbiology
Melanie Winkle, Sherien M. El-Daly, Muller Fabbri, George A. Calin
Summary: In recent years, RNA-based therapies have gained FDA approval, but there are still challenges in targeting ncRNAs. Therapeutic targeting of noncoding RNAs has the potential to become a new approach for treating diseases such as cancer.
NATURE REVIEWS DRUG DISCOVERY
(2021)
Editorial Material
Oncology
Kinga Nemeth, George A. Calin
Summary: The article reviews the current knowledge about the role of circular and linear forms of PVT1 non-coding RNA in cancer and human diseases, highlighting technical challenges and potential biases in publications that researchers need to pay more attention to.
BRITISH JOURNAL OF CANCER
(2022)
Review
Biochemistry & Molecular Biology
Amar Balihodzic, Felix Prinz, Michael A. Dengler, George A. Calin, Philipp J. Jost, Martin Pichler
Summary: Ferroptosis is a distinct form of regulated cell death that differs from traditional programmed cell death. It is associated with various cellular signaling pathways and molecules, and alterations in the ferroptosis-regulating network can contribute to the development of diseases, including cancer. Suppression of ferroptosis is common in cancer cells, allowing them to survive and progress. However, cancer cells resistant to common chemotherapeutic drugs are highly susceptible to ferroptosis inducers, suggesting the potential of targeting ferroptosis for cancer treatment. Non-coding RNAs (ncRNAs) play a crucial role in regulating ferroptosis in cancer and hold promise as therapeutic targets.
CELL DEATH AND DIFFERENTIATION
(2022)
Article
Biochemistry & Molecular Biology
Laura Lupini, Roberta Roncarati, Lorenzo Belluomini, Federica Lancia, Cristian Bassi, Lucilla D'Abundo, Angelo Michilli, Paola Guerriero, Alessandra Fasano, Elisa Tiberi, Andrea Salamone, Donato Michele Cosi, Elena Saccenti, Valentina Tagliatti, Iva Maestri, Silvia Sabbioni, Stefano Volinia, Roberta Gafa, Giovanni Lanza, Antonio Frassoldati, Massimo Negrini
Summary: This study evaluated the usefulness of liquid biopsy in the clinical management of advanced-stage oncogene-addicted non-small-cell lung adenocarcinomas. The results showed that liquid biopsy could detect disease progression earlier and identify new mutations responsible for treatment resistance. The study provided algorithms for the use of liquid biopsy in diagnosis and therapy monitoring.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Oncology
Goknur Kara, Banu Arun, George A. Calin, Bulent Ozpolat
Summary: The discovery of microRNAs has revolutionized cancer treatment and their effective and safe delivery remains a challenge. New nanoparticle-based carriers have enabled successful tumor-targeted delivery of miRNA therapeutics, accelerating the transition of miRNAs from the lab to the bedside.
Review
Oncology
Marianna Aprile, Valerio Costa, Amelia Cimmino, George Adrian Calin
Summary: The view of long noncoding RNAs as nonfunctional garbage has been outdated, as evidence suggests their role as golden junk, particularly in precision oncology. They have potential use as diagnostic and/or prognostic biomarkers, and advancements in technology have made it easier to profile them in multiple tumors and large cohorts.
INTERNATIONAL JOURNAL OF CANCER
(2023)
Article
Oncology
Jody Vykoukal, Johannes F. Fahrmann, Nikul Patel, Masayoshi Shimizu, Edwin J. Ostrin, Jennifer B. Dennison, Cristina Ivan, Gary E. Goodman, Mark D. Thornquist, Matt J. Barnett, Ziding Feng, George A. Calin, Samir M. Hanash
Summary: Blood-based cancer biomarkers, including miRNA and four protein marker panel, have shown utility in improving the assessment and early detection of lung cancer.
Article
Biochemistry & Molecular Biology
Ana Carolina Rodrigues, Erika Pereira Zambalde, Daniel de Lima Bellan, Edvaldo da Silva Trindade, Enilze Maria de Souza Fonseca Ribeiro, George Calin, Daniela Fiori Gradia, Jaqueline Carvalho de Oliveira
Summary: This study aimed to investigate the role of long non-coding RNA lnc-uc.147 in different types of cancer and suggest its functional and regulation aspects. The results showed that deregulated expression of lnc-uc.147 was associated with histologic grade in hepatocellular carcinoma and tumor stage in clear cell renal and gastric adenocarcinoma. Silencing lnc-uc.147 reduced the viability and clonogenic capacity of HepG2 cell lines. Additionally, a relationship between the transcription factor TEAD4 and lnc-uc.147 was suggested in liver and breast cancer cells.
Article
Biochemistry & Molecular Biology
Sergiu Chira, Cristina Ciocan, Cecilia Bica, George A. Calin, Ioana Berindan-Neagoe
Summary: miRNAs are noncoding RNAs that regulate genes and play a key role in cell homeostasis. The interaction between miRNAs and their target mRNAs is believed to depend on sequence complementarity, but some evidence suggests that miRNAs can adopt different structures that affect their function. By studying the oncogenic miR-181 family, we propose that the primary sequence and secondary structure of miRNAs may impact the number and range of targeted cellular transcripts. We also highlight that specific changes in miR-181 primary sequences may limit target gene selection and lead to the targeting of new transcripts with enhanced cancer-related functions.
Review
Biochemistry & Molecular Biology
Giuseppina Pisignano, David C. Michael, Tanvi H. Visal, Radu Pirlog, Michael Ladomery, George A. Calin
Summary: To date, thousands of circRNAs, which are highly abundant and conserved single-stranded RNA molecules shaped into ring structures, have been identified. CircRNAs have been shown to regulate gene expression and exhibit tissue- and development-specific expression patterns associated with normal and disease conditions, including cancer. They have drawn attention as potential diagnostic and prognostic biomarkers in cancer due to their stability and resistance to ribonucleases. However, their circular shape limits their annotation and a complete understanding of their functions is still lacking, making their detection and biomedical application challenging.
Review
Genetics & Heredity
Kinga Nemeth, Recep Bayraktar, Manuela Ferracin, George A. Calin
Summary: Non-coding RNAs (ncRNAs) are a group of transcripts that are not translated into proteins. They play important roles in regulating biological functions and are implicated in disease. In this review, the authors summarize the roles of miRNAs, lncRNAs, and circRNAs in cancer and other major human diseases, and discuss their potential as biomarkers and therapeutic targets.
NATURE REVIEWS GENETICS
(2023)
Review
Biochemistry & Molecular Biology
BaoQing Chen, Mihnea P. Dragomir, Chen Yang, Qiaoqiao Li, David Horst, George A. Calin
Summary: Non-coding RNAs (ncRNAs), especially microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), play a crucial role in regulating resistance to different cancer therapies by rewiring essential signaling pathways. ncRNAs have the potential to serve as biomarkers for predicting and detecting resistance to treatment, and targeting ncRNAs may be a strategy to overcome cancer treatment resistance.
SIGNAL TRANSDUCTION AND TARGETED THERAPY
(2022)
Article
Oncology
Caitrin Crudden, Takashi Shibano, Dawei Song, Mihnea P. Dragomir, Sonia Cismas, Julianna Serly, Daniela Nedelcu, Enrique Fuentes-Mattei, Andrei Tica, George A. Calin, Ada Girnita, Leonard Girnita
Summary: This study elucidates the molecular and biological roles of biased signaling downstream RTK, providing a novel approach to enhance the efficacy of anti-IGF1R-targeted therapy in cancer by targeting system bias. The findings suggest a promising strategy for the rational design or repurposing of therapeutics to selectively cross-target the IGF1R or other RTK.